Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score

被引:1
|
作者
Berezin, Alexander E. [1 ]
Peterlin, Borut [2 ]
Lichtenauer, Michael [3 ]
Mozos, Ioana [4 ]
机构
[1] State Med Univ, Minist Hlth Ukraine, Internal Med Dept, Zaporizhzhia, Ukraine
[2] Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia
[3] Paracelsus Med Univ Salzburg, Dept Internal Med 2, Div Cardiol, Salzburg, Austria
[4] Victor Babes Univ Med & Pharm, Ctr Translat Res & Syst Med, Dept Funct Sci Pathophysiol, Timisoara, Romania
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
关键词
heart failure; biomarkers; stratification; prediction; risk scores;
D O I
10.3389/fcvm.2021.687232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Increased Circulating Myostatin is Predictive of Mortality in Congestive Heart Failure
    Gruson, Damien
    Lepoutre, Thibault
    Ahn, Sylvie A.
    Cumps, Jean
    Ketelslegers, Jean-Marie
    Rousseau, Michel F.
    CIRCULATION, 2011, 124 (21)
  • [22] The Link Between Heart Failure and Neurodegeneration Insights From Circulating Biomarkers
    Traub, Jan
    Docherty, Kieran F.
    Frey, Anna
    JACC-HEART FAILURE, 2024, 12 (06) : 1086 - 1088
  • [23] Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction
    Schreuder, M. M.
    Schuurman, A.
    Akkerhuis, K. M.
    Constantinescu, A. A.
    Caliskan, K.
    van Ramshorst, J.
    Germans, T.
    Umans, V. A.
    Boersma, E.
    van Lennep, J. E. Roeters
    Kardys, I.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 334 : 126 - 134
  • [24] Predictive Value of Biomarkers in Patients with Heart Failure
    Tousoulis, D.
    Oikonomou, E.
    Siasos, G.
    Chrysohoou, C.
    Charakida, M.
    Siasou, Z.
    Limperi, M.
    Papadimitriou, E. D.
    Papavassiliou, A. G.
    Stefanadis, C.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (16) : 2534 - 2547
  • [25] Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients
    Wei, Haoran
    Wu, Junfang
    Wang, Huiqing
    Huang, Jin
    Li, Chenze
    Zhang, Yuxuan
    Song, Yaonan
    Zhou, Zhitong
    Sun, Yang
    Xiao, Lei
    Peng, Liyuan
    Chen, Chen
    Zhao, Chunxia
    Wang, Dao Wen
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (04) : 515 - 530
  • [26] Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
    Nymo, Stale H.
    Aukrust, Pal
    Kjekshus, John
    McMurray, John J. V.
    Cleland, John G. F.
    Wikstrand, John
    Muntendam, Pieter
    Wienhues-Thelen, Ursula
    Latini, Roberto
    Askevold, Erik Tandberg
    Gravning, Jorgen
    Dahl, Christen P.
    Broch, Kaspar
    Yndestad, Arne
    Gullestad, Lars
    Ueland, Thor
    JACC-HEART FAILURE, 2017, 5 (04) : 256 - 264
  • [27] Prognostic Value of Combined Biomarkers in Patients With Heart Failure: The Heartmarker Score
    van der Stam, Jonna A.
    Bouwmeester, Sjoerd
    van Loon, Saskia L. M.
    van Riel, Natal A. W.
    Dekker, Lukas R.
    Boer, Arjen-Kars
    Houthuizen, Patrick
    Scharnhorst, Volkher
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) : 253 - 262
  • [28] Metabolic Pathways and Risk Biomarkers for Incident Heart Failure
    Snow, Sarah C.
    Kwee, Lydia
    Selvaraj, Senthil
    Rao, Vishal
    Patel, Manesh R.
    Pagidipati, Neha J.
    Shah, Svati H.
    CIRCULATION, 2023, 148
  • [29] Circulating Circular RNAs: Novel Biomarkers for Heart Failure
    Sun, Chuan
    Ni, Mingming
    Song, Bo
    Cao, Lu
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [30] Heart failure risk estimation based on novel biomarkers
    Ataklte, Feven
    Vasan, Ramachandran S.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021, 21 (07) : 655 - 672